Labao, Loreta D.
HRN: 07-43-77 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CEFTRIAXONE 1G (VIAL)
10/24/2022
10/30/2022
IV
2g
Q24
UTI
Waiting Final Action